ARS Pharmaceuticals Inc. (SPRY)
NASDAQ: SPRY
· Real-Time Price · USD
9.66
0.12 (1.26%)
At close: Sep 26, 2025, 1:14 PM
ARS Pharmaceuticals Revenue
ARS Pharmaceuticals reported an annual revenue of $89.15M, reflecting a 297063.33% growth. For the quarter ending June 30, 2025, ARS Pharmaceuticals generated $15.72M in revenue.
Revenue (ttm)
89.15M
Revenue Growth
297063.33%
Price / Sales Ratio
11.47
Revenue / Employee
575.15K
Employees
155
Market Cap
944.14M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 89.15M | +297063.33% |
| Dec 31, 2023 | 30K | -97.72% |
| Dec 31, 2022 | 1.32M | -76.10% |
| Dec 31, 2021 | 5.51M | -69.13% |
| Dec 31, 2020 | 17.84M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |